Filing Flows › Comparisons › EW vs ALGN
Edwards Lifesciences vs Align Technology: EW and ALGN compared
Edwards Lifesciences is the larger company: $1.7B of revenue in its latest quarter (Q3 2026) against $1.0B for Align Technology (Q3 2026). Edwards Lifesciences is growing faster (+10% against +2% a year earlier). Edwards Lifesciences is more profitable, with an operating margin of 17.4% against 16.7%.
Where the money goes: EW and ALGN
Edwards Lifesciences (EW) · Q3 2026
Edwards Lifesciences, Q3 2026: revenue $1.7B (+10% year over year), operating margin 17.4%, net earnings $308M, operating cash flow $570M. The chart follows the revenue to costs, profit and cash.
Align Technology (ALGN) · Q3 2026
Align Technology, Q3 2026: revenue $1.0B (+2% year over year), operating margin 16.7%, net earnings $135M, operating cash flow $183M. The chart follows the revenue to costs, profit and cash.
| Edwards Lifesciences (EW) | Align Technology (ALGN) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $1.7B | $1.0B |
| Revenue growth, Y/Y | +10% | +2% |
| Gross margin | 78.5% | 68.7% |
| Operating margin | 17.4% | 16.7% |
| Net earnings | $308M | $135M |
| Net margin | 17.9% | 13.3% |
| Operating cash flow | $570M | $183M |
| Free cash flow | $507M | $138M |
| Market value | $58.6B | $11.8B |
| P/E | 57.3× | 24.2× |
| Analysts’ mean target | $111.64 | $185.79 |
Where the revenue comes from
Edwards Lifesciences
- Transcatheter Aortic Valve Replacement: $1.2B (72%)
- Surgical: $264M (15%)
- Transcatheter Mitral and Tricuspid Therapies: $210M (12%)
Questions
Which is bigger, Edwards Lifesciences or Align Technology?
Edwards Lifesciences is the larger company: $1.7B of revenue in its latest quarter (Q3 2026) against $1.0B for Align Technology (Q3 2026).
Is Edwards Lifesciences or Align Technology growing faster?
Edwards Lifesciences is growing faster (+10% against +2% a year earlier).
Which is more profitable, Edwards Lifesciences or Align Technology?
Edwards Lifesciences is more profitable, with an operating margin of 17.4% against 16.7%.
More: Edwards Lifesciences earnings · how Edwards Lifesciences makes money · Align Technology earnings · how Align Technology makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 4, 2026; 10-Q filed Nov 4, 2026). Fiscal quarters can end on different dates. Not investment advice.